Beta Bionics Touts Pharmacy Push, iLet Momentum and 2027 Mint Patch Pump Plans
Beta Bionics (NASDAQ:BBNX) Chief Financial Officer Stephen Feider said the company’s first-quarter outperformance was supported by increasing use of the pharmacy reimbursement channel, expanded sales...
Beta Bionics: The FDA Remediation Deadline Arrives as Growth Momentum Gets Its First Real Test
Barchart Research What to Expect from BBNX Earnings BBNX Generated April 20, 2026 Current Price $12.91 EPS Estimate $$-0.53 Consensus Rating Moderate Buy Average Move 13.49% Beta Bionics: The FDA Remediation...
Artificial Pancreas Maker Beta Bionics Just Started Trading. Should You Buy BBNX Stock After Its IPO?
This healthcare technology company is guiding for revenue growth of 150% for Q4.